Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
VRTX delivered .0B in FY2025 revenue (+9% YoY), net income .0B (.32 EPS), 86.2% gross margin, 34.8% operating margin, .1B cash, zero long-term debt. CF franchise (~75% patient penetration) remains the...